Rewiring Tumor Cell State in Cancer Therapy: Comment on '9-cis-UAB30, a Novel Rexinoid Agonist, Decreases Tumorigenicity and Cancer Cell Stemness of Human Neuroblastoma Patient-Derived Xenografts' by 'Elizabeth Beierle et al.'
Transl Oncol. 2021 Jan;14(1):100967.
doi: 10.1016/j.tranon.2020.100967.
Epub 2020 Dec 1.
1 Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.. Electronic address: chakraa@ccf.org.